Unique ID issued by UMIN | UMIN000011469 |
---|---|
Receipt number | R000013400 |
Scientific Title | Assessment of diminished peristalsis using shakuyakukanzoto as premedication for endoscopic retrograde cholangiopancreatography |
Date of disclosure of the study information | 2013/11/30 |
Last modified on | 2013/08/13 13:48:09 |
Assessment of diminished peristalsis using shakuyakukanzoto as premedication for endoscopic retrograde cholangiopancreatography
Shakuyakukanzoto for ERCP
Assessment of diminished peristalsis using shakuyakukanzoto as premedication for endoscopic retrograde cholangiopancreatography
Shakuyakukanzoto for ERCP
Japan |
Patients scheduled for ERCP at Toyama University Hospital
Gastroenterology |
Others
NO
Shakuyakukanzoto is a Kampo medicine, which is a part of traditionally practiced Japanese-based ancient Chinese medicine, reduces abdominal pain and muscular cramps quickly. Furthermore, it was reported that Shyakuyakukanzoto was suppressed the contractions of ileum. We reported that the inhibitory effect of Shakuyakukanzoto on duodenal peristalsis during ERCP at Japan Digestive Disease Week 2006, and Sakai et al. reported the confirmation of the suppressive effect of Shakuyakukanzoto on duodenal spasm during ERCP. These previous studies indicated that the inhibitory effect of Shyakuyakukanzoto on duodenal peristalsis. Our aim of this study is to the placebo-controlled trial to evaluate the clinical efficacy and safety of Shakuyakukanzoto as a premedication for ERCP.
Efficacy
Confirmatory
Duodenal peristalsis stop rate after administration of Shyakuyakukanzoto
Measured a required time (RT) from administering premedication to diminished peristalsis and a peristalsis stop duration time (DT)
Interventional
Parallel
Randomized
Open -no one is blinded
Placebo
2
Prevention
Medicine |
Shakuyakukanzoto solution was contained 5.0 g of Shakuyakukanzoto extract dissolved in 50 ml of warm water (36 degrees Celsius). As the premedication, the Shakuyakukanzoto solution was administered by spraying directly toward the major papilla of the duodenum through the endoscopy.
As a control, 50 ml of warm water (36 degrees Celsius) was prepared.
As the premedication, warm water (placebo ) was administered by spraying directly toward the major papilla of the duodenum through the endoscopy.
20 | years-old | <= |
85 | years-old | >= |
Male and Female
patients need ERCP examination.
(1) Inability to provide written informed consent; (2) Inability to access duodenal papilla endoscopically; (3) Patients with ischemic heart disease, prostatic hypertrophy or glaucoma; (4) Patients with acute pancreatitis; (5) Serum K level >5.0 mEq/L
30
1st name | |
Middle name | |
Last name | Toshiro Sugiyama |
University od Toyama
Department of Gastroenterology
2630 Sugitani, Toyama, Japan
1st name | |
Middle name | |
Last name |
University of Toyama
Department of Gastroenterology
2630 Sugitani, Toyama
University of Toyama, Department of Gastroenterology
None
Other
NO
2013 | Year | 11 | Month | 30 | Day |
Unpublished
Completed
2006 | Year | 05 | Month | 15 | Day |
2006 | Year | 05 | Month | 15 | Day |
2010 | Year | 10 | Month | 30 | Day |
2010 | Year | 11 | Month | 30 | Day |
2013 | Year | 08 | Month | 12 | Day |
2013 | Year | 08 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013400
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |